5DLZ | pdb_00005dlz

FIRST DOMAIN OF HUMAN BROMODOMAIN BRD4 IN COMPLEX WITH INHIBITOR 4-[(1-methyl-2-oxo-1,2-dihydroquinolin-4-yl)oxy]-N-({1-[(3-methylphe methyl]piperidin-4-yl}methyl)butanamide

CHAIN

A

Dd_d12_09_d12 - synthetic construct

Explore Sequence Annotations in 3D

CHAIN A

SECONDARY STRUCTURE

UNMODELED

EDS ATOMS

OCC WT AVG B

AVERAGE OCCUPANCY

ATOMIC CLASHES

RSRZ

RSR

RSCC

BINDING SITE GOL

BINDING SITE GOL

BINDING SITE GOL

BINDING SITE GOL

BINDING SITE GOL

BINDING SITE SO4

BURIED RESIDUES

HYDROPATHY

DISORDER

DISORDERED BINDING

ECOD

LOADING 96%

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.